Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. - Wikidata - wikimedia - TriplyDB

Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.

Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.

http://www.wikidata.org/entity/Q38025713

about

Potential benefits of berberine in the management of perimenopausal syndrome.Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects.Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis.Anti-infective potential of Citrus bergamia Risso et Poiteau (bergamot) derivatives: a systematic review.Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients.

P2860

Q35138347-52514115-2288-480C-B965-656ED15E0620 Q36263531-002C654E-3833-40CB-A0F4-AE3DBC24524D Q38374348-A9C94F97-3347-4934-9985-7C8BC5035650 Q38665744-CCB0EFB5-6674-4DB1-96D9-C3BFC02F39B3 Q38727970-3F133112-6916-4C87-A1B4-CD498E29AB48 Q38842926-E22C82E1-86BE-42B8-A9A5-2427BBE5415C Q39658352-373E7509-076A-42FA-A4E6-9D151540C535 Q41549715-5C2E630F-A925-4BCA-BC65-4735431F4C93 Q41556611-235C2F98-96EA-4480-9A4A-9FE51E65E111 Q47716717-1C227B4D-61A7-4408-808C-410FF82B902F

P2860

Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.

http://www.wikidata.org/entity/Q38025713

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Tolerability and safety of com ...... s with lipid-lowering effects.

@en

type

label

Tolerability and safety of com ...... s with lipid-lowering effects.

@en

prefLabel

Tolerability and safety of com ...... s with lipid-lowering effects.

@en

P1433

Q38025713-0BCF2827-4A10-4727-8C4F-17C3D2DA0416

P1476

Q38025713-297DBFA6-8212-4C16-8954-41CAE5E55C46

P2093

Q38025713-126B4C0C-34D1-4883-8C41-0ACFA240CA50

Q38025713-7D869082-7918-4DFD-82A5-1C454811D420

P2860

Q38025713-042B8821-6099-4AD2-BA83-8FC2DDC0AB0A

Q38025713-09713049-1995-4F0B-8B42-51AF771293B2

Q38025713-0BFE3760-505F-46F6-AE6D-3C1F74A375A9

Q38025713-0FA1F065-5681-4977-9B47-3527EADE0316

Q38025713-11C97B63-B1F8-437F-84E8-59BFFA401FD0

Q38025713-12B1E91F-64E6-485E-802F-5D58B73C8E24

Q38025713-192E5181-C2EB-4F13-81D4-FC018B2C59AD

Q38025713-1C183D9E-7AF3-40DF-9C2D-E554EA57A798

Q38025713-237FA726-F527-49ED-A813-75EA8166AC2A

Q38025713-248B9967-C773-4CB2-A831-A577F347932E

P304

Q38025713-EF44031E-1959-4B36-A5BC-41BD74429747

P31

Q38025713-CC9FBC84-6B0D-4E5A-A604-29BDD851191E

P356

Q38025713-A4DD89B8-F73D-4F1A-B730-A0ABBA42BBCA

P407

Q38025713-5667AAEF-0C9C-4350-8CF6-D02B6D8AA6BA

P433

Q38025713-E3ACDCC4-4726-4E65-989B-16E1CE9DE353

P478

Q38025713-2A5D5CDC-CB7F-4BC6-94D8-58E59D2C3188

P50

Q38025713-6A774646-027A-41E0-877F-8397A58647F9

P577

Q38025713-976AE4E3-99A9-45EC-87B4-A0EB57ABE994

P5875

Q38025713-DC7159B2-9B7B-48FD-9F94-7FD06644A181

P698

Q38025713-67041070-3F13-4C3E-96B6-2ED406A98159

P356

14740338.2012.705827

P1433

Expert Opinion on Drug Safety

P1476

Tolerability and safety of com ...... ls with lipid-lowering effects

@en

P2093

Alienor Ferroni

http://www.w3.org/2001/XMLSchema#string

Sibel Ertek

http://www.w3.org/2001/XMLSchema#string

P2860

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials

Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE-/- mice

Efficacy of berberine in patients with type 2 diabetes mellitus

Controversial role of plant sterol esters in the management of hypercholesterolaemia

Hypertensive crisis associated with high dose soy isoflavone supplementation in a post-menopausal woman: a case report [ISRCTN98074661].

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial

Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all

P304

753-766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2012.705827

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Arrigo F. Cicero

P577

2012-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229080094

http://www.w3.org/2001/XMLSchema#string

P698

22788832

http://www.w3.org/2001/XMLSchema#string